Ajanta Pharma [AJANTPHARM] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison
Ajanta Pharma
NSE
Loading...
Dr. Reddy's
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ajanta Pharma wins in 9 metrics, Dr. Reddy's wins in 11 metrics, with 0 ties. Dr. Reddy's appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ajanta Pharma | Dr. Reddy's | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.23 | 17.96 | Dr. Reddy's |
| Price-to-Book Ratio | 8.94 | 2.91 | Dr. Reddy's |
| Debt-to-Equity Ratio | 1.34 | 13.75 | Ajanta Pharma |
| PEG Ratio | 27.17 | 3.57 | Dr. Reddy's |
| EV/EBITDA | 25.79 | 11.20 | Dr. Reddy's |
| Profit Margin (TTM) | 19.35% | 16.99% | Ajanta Pharma |
| Operating Margin (TTM) | 25.73% | 20.50% | Ajanta Pharma |
| EBITDA Margin (TTM) | 25.73% | 20.50% | Ajanta Pharma |
| Return on Equity | 24.28% | 17.71% | Ajanta Pharma |
| Return on Assets (TTM) | 18.35% | 9.71% | Ajanta Pharma |
| Free Cash Flow (TTM) | $8.39B | $12.03B | Dr. Reddy's |
| Dividend Yield | 1.08% | 11.59% | Dr. Reddy's |
| 1-Year Return | -10.33% | -7.24% | Dr. Reddy's |
| Price-to-Sales Ratio (TTM) | 7.01 | 3.05 | Dr. Reddy's |
| Enterprise Value | $333.36B | $1,001.39B | Dr. Reddy's |
| EV/Revenue Ratio | 6.94 | 3.00 | Dr. Reddy's |
| Gross Profit Margin (TTM) | 78.82% | 56.91% | Ajanta Pharma |
| Revenue per Share (TTM) | $385 | $401 | Dr. Reddy's |
| Earnings per Share (Diluted) | $74.45 | $68.17 | Ajanta Pharma |
| Beta (Stock Volatility) | 0.17 | 0.31 | Ajanta Pharma |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ajanta Pharma vs Dr. Reddy's Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ajanta Pharma | 0.53% | 2.55% | 1.49% | 3.85% | 4.91% | -10.30% |
| Dr. Reddy's | 0.56% | 4.96% | 0.78% | 3.31% | 5.29% | -7.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -10.33% | 107.06% | 65.57% | 64.08% | 8,462.00% | 22,189.63% |
| Dr. Reddy's | -7.24% | 49.90% | 40.36% | 48.49% | 375.21% | 1,436.32% |
Performance & Financial Health Analysis: Ajanta Pharma vs Dr. Reddy's
| Metric | AJANTPHARM | DRREDDY |
|---|---|---|
| Market Information | ||
| Market Cap | ₹336.99B | ₹1.02T |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 77,505 | 1,372,800 |
| 90 Day Avg. Volume | 145,930 | 1,382,405 |
| Last Close | ₹2,685.90 | ₹1,260.40 |
| 52 Week Range | ₹2,327.30 - ₹3,485.00 | ₹1,020.00 - ₹1,421.49 |
| % from 52W High | -22.93% | -11.33% |
| All-Time High | ₹3,485.00 (Sep 09, 2024) | ₹1,421.49 (Aug 19, 2024) |
| % from All-Time High | -22.93% | -11.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.11% |
| Quarterly Earnings Growth | 0.04% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.17% |
| Operating Margin (TTM) | 0.26% | 0.21% |
| Return on Equity (TTM) | 0.24% | 0.18% |
| Debt to Equity (MRQ) | 1.34 | 13.75 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹301.59 | ₹420.56 |
| Cash per Share (MRQ) | ₹48.84 | ₹80.12 |
| Operating Cash Flow (TTM) | ₹12.01B | ₹52.56B |
| Levered Free Cash Flow (TTM) | ₹9.20B | ₹14.23B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.08% | 11.59% |
| Last 12-Month Dividend | ₹28.00 | ₹146.30 |
Valuation & Enterprise Metrics Analysis: Ajanta Pharma vs Dr. Reddy's
| Metric | AJANTPHARM | DRREDDY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.23 | 17.96 |
| Forward P/E | 27.17 | 3.57 |
| PEG Ratio | 27.17 | 3.57 |
| Price to Sales (TTM) | 7.01 | 3.05 |
| Price to Book (MRQ) | 8.94 | 2.91 |
| Market Capitalization | ||
| Market Capitalization | ₹336.99B | ₹1.02T |
| Enterprise Value | ₹333.36B | ₹1.00T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.94 | 3.00 |
| Enterprise to EBITDA | 25.79 | 11.20 |
| Risk & Other Metrics | ||
| Beta | 0.17 | 0.31 |
| Book Value per Share (MRQ) | ₹301.59 | ₹420.56 |
Financial Statements Comparison: Ajanta Pharma vs Dr. Reddy's
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AJANTPHARM | DRREDDY |
|---|---|---|
| Revenue/Sales | ₹13.03B | ₹85.45B |
| Cost of Goods Sold | ₹2.76B | ₹36.83B |
| Gross Profit | ₹10.27B | ₹48.63B |
| Research & Development | N/A | ₹6.24B |
| Operating Income (EBIT) | ₹6.83B | ₹16.84B |
| EBITDA | ₹3.78B | ₹23.41B |
| Pre-Tax Income | ₹3.31B | ₹19.05B |
| Income Tax | ₹757.90M | ₹4.95B |
| Net Income (Profit) | ₹2.55B | ₹14.10B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AJANTPHARM | DRREDDY |
|---|---|---|
| Cash & Equivalents | ₹1.75B | ₹14.65B |
| Total Current Assets | ₹28.43B | ₹250.11B |
| Total Current Liabilities | ₹9.96B | ₹130.39B |
| Long-Term Debt | ₹347.20M | ₹7.86B |
| Total Shareholders Equity | ₹37.90B | ₹337.17B |
| Retained Earnings | ₹36.72B | ₹315.79B |
| Property, Plant & Equipment | ₹17.16B | ₹0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AJANTPHARM | DRREDDY |
|---|---|---|
| Operating Cash Flow | N/A | ₹27.79B |
| Capital Expenditures | N/A | ₹-7.67B |
| Free Cash Flow | N/A | ₹10.75B |
| Debt Repayment | N/A | ₹-253.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AJANTPHARM | DRREDDY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 77,505 | 1,372,800 |
| Average Daily Volume (90 Day) | 145,930 | 1,382,405 |
| Shares Outstanding | 124.91M | 832.00M |
| Float Shares | 42.11M | 595.10M |
| % Held by Insiders | 0.60% | 0.29% |
| % Held by Institutions | 0.22% | 0.50% |
Dividend Analysis & Yield Comparison: Ajanta Pharma vs Dr. Reddy's
| Metric | AJANTPHARM | DRREDDY |
|---|---|---|
| Last 12-Month Dividend | ₹28.00 | ₹146.30 |
| Last 12-Month Dividend Yield | 1.08% | 11.59% |
| 3-Year Avg Annual Dividend | ₹25.33 | ₹49.30 |
| 3-Year Avg Dividend Yield | 0.90% | 3.74% |
| 3-Year Total Dividends | ₹76.00 | ₹147.90 |
| Ex-Dividend Date | Nov 06, 2024 | Jul 10, 2025 |